HyQvia®
HYQVIA is a liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
MANUFACTURER: Takeda Pharmaceuticals U.S.A., Inc. |
CLASS: Human immunoglobulins |
WHAT IT TREATS: Immunodeficiency Chronic inflammatory demyelinating polyneuropathy |
PRESCRIBED BY:
|
HOW ADMINISTERED: Intravenous Infusion |
FREQUENCY: The first dose is administered approximately one week after the last infusion of previous treatment. Then the dose and frequency is increases from a 1-week dose to a 3-or 4-week dose. |
Length of infusion: Less than 3 hours |
FOR MORE INFORMATION: |
